about
Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulationNeuronal T-type calcium channels: what's new? Iftinca: T-type channel regulationThe Discovery and Characterization of ML218: A Novel, Centrally Active T-Type Calcium Channel Inhibitor with Robust Effects in STN Neurons and in a Rodent Model of Parkinson's Disease.Eps15 Homology Domain-containing Protein 3 Regulates Cardiac T-type Ca2+ Channel Targeting and Function in the AtriaIn silico identification of T-type calcium channel blockers: A ligand-based pharmacophore mapping approachEffects of NB001 and gabapentin on irritable bowel syndrome-induced behavioral anxiety and spontaneous pain.CaV1.2/CaV3.x channels mediate divergent vasomotor responses in human cerebral arteries.Inhibition of human recombinant T-type calcium channels by N-arachidonoyl 5-HTFunctional chromaffin cell plasticity in response to stress: focus on nicotinic, gap junction, and voltage-gated Ca2+ channels.The design and discovery of T-type calcium channel inhibitors for the treatment of central nervous system disorders.Low-voltage-activated T-type Ca2+ channel inhibitors as new tools in the treatment of glioblastoma: the role of endostatin.T-type channel-mediated neurotransmitter release.Functional importance of T-type voltage-gated calcium channels in the cardiovascular and renal system: news from the world of knockout mice.Selectivity filters and cysteine-rich extracellular loops in voltage-gated sodium, calcium, and NALCN channels.Small molecule and peptide therapies for chronic heart failure: a patent review (2011 - 2014).
P2860
Q26853630-5FA0F9A8-082A-491C-A24B-D70A090678E2Q28243759-4E1D7592-97A8-4D39-803B-17FC0A4B137BQ28260708-0977640A-44AF-43A2-A206-0EA130AA7119Q28511764-1D47B926-A757-4636-8B01-AAE00DDC396EQ28828157-FC8494CD-B3C3-47D2-96A0-F08006B367DFQ33807470-07213CAD-4D8C-432A-A8A2-038840A6B459Q35543117-CB92DCA6-E9FA-4ED2-8CE5-2FFF4704891DQ36382959-2B1960A8-5355-4201-8963-B134E52DC50CQ36876604-E5B5FA70-DE28-45DD-9C15-E0BA202E10ECQ38105331-E9F04320-84FC-4A77-B4F2-369D3740FEE8Q38177193-74E12FD9-BDBB-43A4-AA8E-2135E578B91EQ38193331-17D1BED9-DF04-4444-AA6C-4A4FDC346761Q38292292-330151A6-835A-4A88-ADD7-1294611C4ECBQ38515325-2E8DCF6B-D98E-469F-9D45-360EE92FC698Q38546917-F5021A92-3FD7-4BDE-82A7-A37C30C1BE79
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
T-type calcium channels inhibitors: a patent review.
@en
T-type calcium channels inhibitors: a patent review.
@nl
type
label
T-type calcium channels inhibitors: a patent review.
@en
T-type calcium channels inhibitors: a patent review.
@nl
prefLabel
T-type calcium channels inhibitors: a patent review.
@en
T-type calcium channels inhibitors: a patent review.
@nl
P2093
P2860
P1476
T-type calcium channels inhibitors: a patent review.
@en
P2093
Andreas Wållberg
Fabrizio Giordanetto
Laurent Knerr
P2860
P304
P356
10.1517/13543776.2011.536532
P407
P577
2010-11-19T00:00:00Z